[Retracted] Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients

Table 5

Relationship between NLR and PLR changes and the pathological responsiveness before and after nCRT.

Groups	Cases	Pathologically responsive	Pathologically nonresponsive
NLR (pretreatment)
> 2.30	43	18 (41.86)	25 (58.14)	0.048	0.826
≤ 2.30	43	17 (39.53)	26 (60.47)
PLR (pretreatment)
> 142.44	43	15 (34.88)	28 (65.12)	0.050	0.822
≤ 142.44	43	16 (37.21)	27 (62.79)
NLR (posttreatment)
> 2.05	43	16 (37.21)	27 (62.79)	0.434	0.510
≤ 2.05	43	19 (44.19)	24 (55.81)
PLR (posttreatment)
> 152.75	43	18 (41.86)	25 (58.14)	0.094	0.759
≤ 152.75	43	17 (39.53)	27 (61.47)
NLR change
Elevated group	43	17 (39.53)	26 (61.47)	0.199	0.655
Decreased group	43	15 (34.88)	28 (65.12)
PLR change
Elevated group	43	9 (20.93)	34 (79.07)	4.472	0.036
Decreased group	43	21 (48.84)	22 (51.16)